NCT04100018 A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT04083898 Isatuximab, Bendamustine, and Prednisone in Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT04072822 Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis Status COMPLETED Phase PHASE2
NCT04066114 Treg Modulation With CD28 and IL-6 Receptor Antagonists Status COMPLETED Phase PHASE1/PHASE2
NCT04061772 A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma Status UNKNOWN Phase PHASE2
NCT04056754 Study of Abiraterone Acetate in Subjects With Metastatic Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE3
NCT04043494 International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma Status RECRUITING Phase PHASE3
NCT03991884 Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1
NCT03984448 Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT03970577 RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome Status UNKNOWN Phase PHASE2
NCT03959085 Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy Status RECRUITING Phase PHASE3
NCT03952637 A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis Status RECRUITING Phase PHASE1/PHASE2
NCT03952572 Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma Status UNKNOWN Phase PHASE3
NCT03934840 CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone Status COMPLETED Phase PHASE2
NCT03920007 Study of Subretinally Injected ATSN-101 Administered in Patients With Leber Congenital Amaurosis Caused by Biallelic Mutations in GUCY2D Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03914625 A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE3